Our News
GLP-1 and SGLT2 prescribing rises for type 1 diabetes, research shows
The share of people with type 1 diabetes who are prescribed a GLP-1 receptor agonist or SGLT2 inhibitor rose from 0.7 per cent to 8.3 per cent between 2010 and 2023, evidence has shown.
Early onset type 2 diabetes to be the focus of new virtual course
A new eLearning course to improve the treatment and management of early onset type 2 diabetes has been launched by Effective Diabetes Education Now (EDEN).
Exciting line-up announced for national obesity conference
The Obesity & Weight Management Alliance is thrilled to reveal the expert speaker line-up for its 2025 national conference, a must attend event for healthcare professionals dedicated to tackling obesity.
Healthcare professionals invited to join the Obesity & Weight Management Alliance network
The Obesity & Weight Management Alliance is calling on registered healthcare professionals to join its growing network and gain access to free educational resources, events, and updates on the latest best practices in obesity management.
Using C-reactive protein values in patients with DFU infections to guide treatment
Patients with diabetic foot ulcer infection with lower C-reactive protein (CRP) values are at lower risk of adverse outcomes, according to research which set out to examine whether CRP could be used to determine the best point of discharge for hospital patients admitted with infected DFUs.
Canagliflozin may improve haemoglobin levels, study claims
Recent research has shown that canagliflozin was linked to a 2.1 per cent increase in total iron-binding capacity and improved haemoglobin levels for people with chronic kidney disease and type 2 diabetes.
Tackling weight stigma in healthcare: Join our expert-led webinar
Registrations are now open for a free webinar exploring how bias may influence the care and well-being of people living with obesity.
Hypo safety campaign rolled out across UK and Ireland
Hundreds of healthcare sites across the UK and Ireland took part in Hypo Awareness Week.
Call for poster submissions: Obesity & Weight Management Alliance 2025 conference
The Obesity & Weight Management Alliance is excited to announce a call for poster submissions for its highly anticipated 2025 conference, taking place on March 7 at the Thistle London Marble Arch.
Diabetes in the emergency department covered in new CDEP topic
A short training topic on managing diabetes in the emergency department has been launched by the Cambridge Diabetes Education Programme (CDEP).
Voice analysis can screen people for type 2 diabetes with high accuracy, study finds
New research presented at this year’s Annual Meeting of The European Association for the Study of Diabetes in Madrid highlights the potential of using voice analysis to detect undiagnosed type 2 diabetes cases.
New blood test could be an early warning for children with type 2 diabetes
A new type of blood test using lipids could make it easier to identify children at risk of complications around obesity including type 2 diabetes, liver disease and heart disease.
Survey aims to collate key patient characteristics that should be included in future DFU studies
Those with experience of managing diabetic foot ulcer have been invited to take part in a survey aiming to collect the most important baseline patient characteristics which should be reported by studies assessing interventions for diabetic foot ulcers.
EDFN autumn webinar: Diabetes footcare in dark skin tones
The latest EDFN webinar will share guidance and further insights into diabetes footcare in dark skin tones, in light of a new handbook from Diabetes Africa.
Register now for the national obesity and weight management conference
Registrations are now open for the highly anticipated Obesity & Weight Management Alliance 2025 conference.
‘Significant’ link between low Toe Brachial Index and coronary artery disease in people with diabetic foot
New research has highlighted a “significant association” between low Toe Brachial Index (TBI) and the presence of coronary artery disease (CAD) in diabetic foot syndrome patients, suggesting TBI could be a valuable screening tool for identifying CAD within this population.
Semaglutide hydrogel could reduce diabetes shots to once a month
A new drug delivery system can cut the dosing schedule for semaglutide to just once a month, according to new research presented at EASD 2024.
Once weekly insulin efsitora alfa leads to HbA1C reduction similar to daily insulin
The results from clinical trials evaluating once weekly insulin efsitora alfa in adults with type 2 diabetes using basal insulin for the first time have been released.
New research explores the prevalence and outcomes of the diabetic sausage toe
Researchers have published the first study to document the sausage toe as a prevalent presentation of diabetic toe infection.
Tirzepatide may reduce type 2 diabetes progression risk, study suggests
Adults with obesity or overweight and prediabetes had a 94 per cent lower risk of progressing to type 2 diabetes after taking tirzepatide, drugmaker Eli Lilly and Co. reported.